{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T15:08:54Z","timestamp":1695049734648},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cll.2016.01.018","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T04:46:12Z","timestamp":1464237972000},"page":"249-259","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result"],"prefix":"10.1016","volume":"36","author":[{"given":"A. Ashleigh","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred Z.","family":"Abuhamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Warsof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cll.2016.01.018_bib1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1056\/NEJM197003122821105","article-title":"Role of amniocentesis in the intrauterine detection of genetic disorders","volume":"282","author":"Nadler","year":"1970","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2016.01.018_bib2","first-page":"578","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","volume":"371","author":"Bianchi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2016.01.018_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.018_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.clp.2014.08.013","article-title":"Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening","volume":"41","author":"Wagner","year":"2014","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.cll.2016.01.018_bib5","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"Committee Opinion No. 640: cell-free DNA screening for fetal aneuploidy","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.018_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/uog.14693","article-title":"Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies","volume":"45","author":"Evans","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.018_bib7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2016.01.018_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/ajo.12396","article-title":"Emerging issues in invasive prenatal diagnosis: safety and competency in the post-NIPT era","volume":"55","author":"Hui","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.cll.2016.01.018_bib9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/pd.4601","article-title":"Overview of the impact of noninvasive prenatal testing on diagnostic procedures","volume":"10","author":"Warsof","year":"2015","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.cll.2016.01.018_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1701-2163(15)30205-X","article-title":"Prenatal diagnosis procedures and techniques to obtain a diagnostic fetal specimen or tissue: maternal and fetal risks and benefits","volume":"37","author":"Wilson","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.cll.2016.01.018_bib11","unstructured":"American College of Obstetricians and Gynecologists. Prenatal Diagnostic Testing for Genetic Disorders. ACOG Practice Bulletin May 2016."},{"issue":"10","key":"10.1016\/j.cll.2016.01.018_bib12","doi-asserted-by":"crossref","first-page":"e109173","DOI":"10.1371\/journal.pone.0109173","article-title":"Non-invasive prenatal chromosomal aneuploidy testing\u2013clinical experience: 100,000 clinical samples","volume":"9","author":"McCullough","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cll.2016.01.018_bib13","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.018_bib14","first-page":"679","article-title":"Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins","volume":"3","author":"Gr\u00f6mminger","year":"2014","journal-title":"J\u00a0Clin Med"},{"issue":"8","key":"10.1016\/j.cll.2016.01.018_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/pd.4600","article-title":"Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy","volume":"35","author":"Thurik","year":"2015","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.cll.2016.01.018_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/uog.13334","article-title":"Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype","volume":"44","author":"Srebniak","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.018_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12967-015-0569-y","article-title":"Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes","volume":"13","author":"Lebo","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"11","key":"10.1016\/j.cll.2016.01.018_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/pd.4656","article-title":"Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis","volume":"35","author":"Malvestiti","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cll.2016.01.018_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2013.215145","article-title":"Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"60","author":"Wang","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2016.01.018_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","article-title":"Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation","volume":"48","author":"Lui","year":"2002","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.cll.2016.01.018_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/uog.14880","article-title":"Genomic microarray in fetuses with increased nuchal translucency and normal karyotype\u2014a systematic review and meta-analysis","volume":"46","author":"Grande","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.cll.2016.01.018_bib22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1373\/clinchem.2013.216077","article-title":"Use of copy number deletion polymorphisms to assess DNA chimerism","volume":"60","author":"Bruno","year":"2014","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.cll.2016.01.018_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/ctr.12393","article-title":"Preconception counseling, fertility, and pregnancy complications after abdominal organ transplantation: a survey and cohort study of 532 recipients","volume":"28","author":"Rupley","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cll.2016.01.018_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cll.2016.01.018_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1469-0705.1998.12010008.x","article-title":"Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases","volume":"2","author":"Nyberg","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.cll.2016.01.018_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.7863\/jum.2001.20.10.1053","article-title":"Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy","volume":"20","author":"Nyberg","year":"2001","journal-title":"J\u00a0Ultrasound Med"},{"issue":"11","key":"10.1016\/j.cll.2016.01.018_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.7863\/jum.2001.20.11.1153","article-title":"The genetic sonogram in screening for Down syndrome","volume":"20","author":"Smith-Bindman","year":"2001","journal-title":"J\u00a0Ultrasound Med"},{"issue":"10","key":"10.1016\/j.cll.2016.01.018_bib28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7863\/jum.2002.21.10.1087","article-title":"The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester","volume":"21","author":"Bromley","year":"2002","journal-title":"J\u00a0Ultrasound Med"},{"issue":"10","key":"10.1016\/j.cll.2016.01.018_bib29","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.7863\/ultra.33.10.1747","article-title":"What is the importance of second-trimester \u201csoft markers\u201d for trisomy 21 after an 11- to 14-week aneuploidy screening scan?","volume":"33","author":"Bromley","year":"2014","journal-title":"J\u00a0Ultrasound Med"},{"issue":"4","key":"10.1016\/j.cll.2016.01.018_bib30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/0002-9378(95)91322-X","article-title":"Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers","volume":"173","author":"Nyberg","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.018_bib31","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0002-9378(99)70322-4","article-title":"Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center","volume":"181","author":"Sohl","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.018_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/pd.307","article-title":"Second trimester ultrasound screening for chromosomal abnormalities","volume":"22","author":"Shipp","year":"2002","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.cll.2016.01.018_bib33","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1067\/mob.2002.126980","article-title":"Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists","volume":"187","author":"Egan","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.cll.2016.01.018_bib34","doi-asserted-by":"crossref","first-page":"e0131402","DOI":"10.1371\/journal.pone.0131402","article-title":"A\u00a0cost-effectiveness analysis of first trimester non-invasive prenatal screening for fetal trisomies in the United States","volume":"10","author":"Walker","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cll.2016.01.018_bib35","doi-asserted-by":"crossref","first-page":"651.e1","DOI":"10.1016\/j.ajog.2014.06.038","article-title":"Uptake of noninvasive prenatal testing at a large academic referral center","volume":"211","author":"Larion","year":"2014","journal-title":"Am J Obstet Gynecol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121630018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121630018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T04:54:01Z","timestamp":1600664041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027227121630018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S027227121630018X"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.018","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}